These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31420910)

  • 1. Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized α-synuclein.
    Sarafian TA; Yacoub A; Kunz A; Aranki B; Serobyan G; Cohn W; Whitelegge JP; Watson JB
    J Neurosci Res; 2019 Dec; 97(12):1689-1705. PubMed ID: 31420910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).
    Follmer C; Coelho-Cerqueira E; Yatabe-Franco DY; Araujo GD; Pinheiro AS; Domont GB; Eliezer D
    J Biol Chem; 2015 Nov; 290(46):27660-79. PubMed ID: 26381411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.
    Jinsmaa Y; Sullivan P; Gross D; Cooney A; Sharabi Y; Goldstein DS
    Neurosci Lett; 2014 May; 569():27-32. PubMed ID: 24670480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.
    Lima VA; do Nascimento LA; Eliezer D; Follmer C
    ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOPAL is transmissible to and oligomerizes alpha-synuclein in human glial cells.
    Jinsmaa Y; Sullivan P; Sharabi Y; Goldstein DS
    Auton Neurosci; 2016 Jan; 194():46-51. PubMed ID: 26777075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.
    Burke WJ; Kumar VB; Pandey N; Panneton WM; Gan Q; Franko MW; O'Dell M; Li SW; Pan Y; Chung HD; Galvin JE
    Acta Neuropathol; 2008 Feb; 115(2):193-203. PubMed ID: 17965867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein.
    Jinsmaa Y; Cooney A; Sullivan P; Sharabi Y; Goldstein DS
    Neurosci Lett; 2015 Mar; 590():134-7. PubMed ID: 25637699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated α-synuclein.
    Sarafian TA; Littlejohn K; Yuan S; Fernandez C; Cilluffo M; Koo BK; Whitelegge JP; Watson JB
    J Neurosci Res; 2017 Sep; 95(9):1871-1887. PubMed ID: 28117497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.
    Plotegher N; Berti G; Ferrari E; Tessari I; Zanetti M; Lunelli L; Greggio E; Bisaglia M; Veronesi M; Girotto S; Dalla Serra M; Perego C; Casella L; Bubacco L
    Sci Rep; 2017 Jan; 7():40699. PubMed ID: 28084443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
    Jinsmaa Y; Isonaka R; Sharabi Y; Goldstein DS
    J Pharmacol Exp Ther; 2020 Feb; 372(2):157-165. PubMed ID: 31744850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
    Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
    Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.
    Limegrover CS; Yurko R; Izzo NJ; LaBarbera KM; Rehak C; Look G; Rishton G; Safferstein H; Catalano SM
    J Neurosci Res; 2021 Apr; 99(4):1161-1176. PubMed ID: 33480104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
    Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
    Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde adducts inhibit 3,4-dihydroxyphenylacetaldehyde-induced α-synuclein aggregation and toxicity: Implication for Parkinson neuroprotective therapy.
    Kumar VB; Hsu FF; Lakshmi VM; Gillespie KN; Burke WJ
    Eur J Pharmacol; 2019 Feb; 845():65-73. PubMed ID: 30579934
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Carmo-Gonçalves P; Romão L; Follmer C
    ACS Chem Neurosci; 2020 Nov; 11(21):3541-3548. PubMed ID: 33080132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein.
    Carmo-Gonçalves P; do Nascimento LA; Cortines JR; Eliezer D; Romão L; Follmer C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):295-301. PubMed ID: 30249394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease.
    Sivakumar P; Nagashanmugam KB; Priyatharshni S; Lavanya R; Prabhu N; Ponnusamy S
    Neurochem Int; 2023 Jan; 162():105461. PubMed ID: 36460239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein.
    Werner-Allen JW; DuMond JF; Levine RL; Bax A
    Angew Chem Int Ed Engl; 2016 Jun; 55(26):7374-8. PubMed ID: 27158766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP
    Kawahata I; Bousset L; Melki R; Fukunaga K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human α-synuclein.
    Sarafian TA; Ryan CM; Souda P; Masliah E; Kar UK; Vinters HV; Mathern GW; Faull KF; Whitelegge JP; Watson JB
    PLoS One; 2013; 8(5):e63557. PubMed ID: 23667637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.